SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Wirth Edward (Last) (First) (Middle) C/O INVIVO THERAPEUTICS HOLDING CORP. ONE BROADWAY, 14TH FLOOR (Street) CAMBRIDGE MA 02142 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/05/2011	3. Issuer Name and Ticker or Trading Symbol INVIVO THERAPEUTICS HOLDINGS CORP. [ NVIV ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Science Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Thomas B. Rosedale (by Power of Attorney)	12/06/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

INVIVO THERAPEUTICS HOLDINGS CORP.

LIMITED POWER OF ATTORNEY


	This statement confirms that the
 undersigned has authorized and designated
each of Ann Imes, Heather Turner and
Thomas B. Rosedale his attorneys-in-fact
 to (i) prepare, execute and file on behalf
of the undersigned Form ID or any other
necessary documents or forms in order to
obtain access codes (including, without
limitation, CIK and CCC codes) for the
undersigned to permit filing on EDGAR, and
(ii) prepare, execute and file on behalf
of the undersigned all Forms 3, 4 and
5 (including any amendments thereto) that
the undersigned may be required to file with
the U.S. Securities and Exchange Commission
as a result of the undersigned's ownership of or
transactions in securities of InVivo Therapeutics
Holdings Corp.  The authority of such attorneys
under this Power of Attorney shall continue until
the undersigned is no longer required to file Forms
3, 4 and 5 with regard to the undersigned's ownership
of or transactions in securities of InVivo Therapeutics
Holdings Corp., unless earlier revoked in writing.  The
undersigned acknowledges that such attorneys are not
assuming any of the undersigned's responsibilities to
comply with the requirements of Section 16 of the
Securities Exchange Act of 1934, as amended, or any
of the undersigned's liabilities for failure to comply
with such requirements.

				/s/   Edward Wirth
Date: October 12, 2011 		-----------------------------
				Name: Edward Wirth